Calcium and Bone
We consider it an exciting time to lead the ESE Focus Area on Calcium and Bone. With studies on the underlying pathogenic mechanisms of classical bone diseases, such as osteoporosis, advancing rapidly, it has also become clear in recent years that the role of bone tissue goes far beyond the obvious functions of the skeleton. It is now evident that calcified tissue behaves as an endocrine organ that interacts with many other body systems. This makes the study of calcium and bone of greater relevance to many endocrinologists. Through recent developments in bone research, many insights have been generated regarding the mechanisms underlying skeletal disease, paving the way for novel treatments that are currently under development both for rare and common diseases. We hope to improve upon the great work already in place in this Focus Area, increasing communication and collaboration and working towards better medical outcomes for bone disorders. Lars Rejnmark, Denmark, Clinical Lead. Wim van Hul, Belgium, Basic Lead.
News
Latest Focus Area News
Latest ESE News
- Calling all ESE Members! Tell us what you think about the Society in the 2018 ESE Member Survey (11 Apr 2018)
- Obituary: Theo Visser (6 Apr 2018)
- Announcing the ESE AGHD Audit: Launch workshop at ECE 2018, Barcelona, Spain. (28 Mar 2018)
- ESE endorses call for increased EU funding for health research (26 Mar 2018)
Highlighted Content
Upper gastrointestinal symptoms, endoscopic and pathological features, and serum gastrin and chromogranin A levels in patients with primary hyperparathyroidism
The Results of Parathormone Assay in Parathyroid Aspirates in Preoperative Localization of Parathyroid Adenomas for Focused Parathyroidectomy in Patients with Negative or Suspicious Sestamibi Scans
High prevalence of radiological vertebral fractures in patients with differentiated thyroid carcinoma undergoing L-thyroxine TSH-suppressive therapy
A practice review of the use of cinacalcet in primary hyperparathyroidism
High prevalence of radiological vertebral fractures in patients with differentiated thyroid carcinoma undergoing L-thyroxine TSH-suppressive therapy
Drug induced osteoporosis
Modern spectrum of bone turnover markers - Are they clinically useful?
Congenital hypoparathyroidism
Alberto Pereira reflects on his ECE 2017 Introduction to the ENDO-ERN network
AJ van der Lely and Matthias Tschop reflect on the ECE 2017 Geoffrey Harris Prize Lecture
Barbara Obermayer-Pietsch and Bente Langdahl reflect on the ECE 2017 Drug Holiday in Osteoporosis debate
Lars Rejnmark - Calcium and Bone Clinical Focus Lead: ECE 17 Reflections
The Results of Parathormone Assay in Parathyroid Aspirates in Preoperative Localization of Parathyroid Adenomas for Focused Parathyroidectomy in Patients with Negative or Suspicious Sestamibi Scans
Secondary hyperparathyroidism and its implication on bone mineral density in patients with different stages of chronic kidney disease
Congenital fibrous dysplasia and Klinefelter syndrome: coincidence or not?
CALCIFEDIOL IS MORE EFFECTIVE THAN CHOLECALCIFEROL IN THE TREATMENT OF SEVERE VITAMIN D DEFICIENCY IN A PATIENT SUBMITTED TO MALABSORBITIVE BARIATRIC SURGERY: A CASE REPORT
Upper gastrointestinal symptoms, endoscopic and pathological features, and serum gastrin and chromogranin A levels in patients with primary hyperparathyroidism
A practice review of the use of cinacalcet in primary hyperparathyroidism
Adolescent Onset Distal Renal Tubular Acidosis Presenting With Significant Growth Retardation Without Rickets.
Beta-2 adrenergic receptor (ADRB2) gene polymorphism Arg16Gly as risk factor for osteoporosis.
MANAGEMENT OF ENDOCRINE DISEASE: The effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover – a systematic review and meta-analysis
European Journal of Endocrinology: Browse the latest content now
Focus Area Events
Guidelines
- European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
- External Guideline: Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- External Guideline: Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group
- External Guideline: Clinical guidelines for management of bone health in Rett syndrome based on expert consensus and available evidence
- External Guideline: Revisiting KDIGO clinical practice guideline on chronic kidney disease—mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference
- External Guideline: Vitamin D supplementation guidelines
- External Guideline: The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism